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Abstract 
 
The contribution of Clostridium difficile toxin A and B (TcdA and TcdB) to cellular 
intoxication has been extensively studied, but their impact on bacterial colonization remains 
unclear. By setting-up two- and three-dimensional in vitro models of polarized gut 
epithelium, we investigated how C. difficile infection is affected by host cell polarity and 
whether TcdA and TcdB contribute to such events. Indeed, we observed that C. difficile 
adhesion and penetration of the epithelial barrier is substantially enhanced in poorly polarized 
or EGTA-treated cells, indicating that bacteria bind preferentially to the basolateral cell 
surface. In this context, we demonstrated that sub-lethal concentrations of C. difficile TcdA 
are able to alter cell polarity by causing redistribution of plasma membrane components 
between distinct surface domains. Taken together, the data suggest that toxin-mediated 
modulation of host cell organization may account for the capacity of this opportunistic 
pathogen to gain access to basolateral receptors leading to a successful colonization of the 
colonic mucosa. 
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Chapter 1: Introduction 
 
Discovery and development of antimicrobial agents was undoubtedly at the forefront of 
research in the 20th century with one of the first and still most widely used antibiotics - 
penicillin. Given its potent activity against various kinds of bacteria, penicillin was 
immediately recognized and subsequently used as a therapeutic agent for the treatment of 
many infectious diseases. However the collateral biological cost of this broad-spectrum 
activity has been identified only recently. Unrelenting rise in the occurrence of antimicrobial 
resistance by many common human pathogens and decrease in the effectiveness of 
vancomycin, which is seen as the last line of defence against many microorganisms, have 
demonstrated the importance of the commensal microbiota for human health. For instance 
destruction of intestinal microflora by antibiotic treatment has been identified as the first and 
essential step in the pathogenesis of infectious diarrhoea caused by Clostridium difficile.  
C. difficile is a Gram-positive, obligate anaerobic, spore-forming bacterium which has 
recently emerged as a significant pathogen of the human gastrointestinal tract. While it is 
found as a part of the commensal flora only in up to 3% of healthy adults, upon antibiotic 
treatment it efficiently colonizes gut leading to a broad range of disease manifestations 
ranging from asymptomatic carriage, mild diarrhoea to life-threating toxic megacolon and 
pseudomembranous colitis (PMC). [1, 2]. Acquisition of C. difficile occurs by oral ingestion 
of spores that resist the acidity of stomach and germinate into vegetative bacteria in the small 
intestine. Upon reaching colon C. difficile adheres and becomes pathogenic through 
production of two potent toxins, TcdA and TcdB. Both toxins belong to the family of large 
clostridial glucosylating toxins and inactivate host GTPases (including Rho, Rac, and Cdc42), 
leading to alteration of the epithelial barrier, damage to human intestinal mucosa, and 
inflammation of the colon [3-6]. The high rate of recurrent disease, even after repeated 
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antimicrobial treatments [7], suggests that C. difficile has evolved mechanisms to persist in 
the intestinal tract. This long-term establishment is likely mediated by multiple colonization 
strategies. While the effects of toxins on epithelial cells have been largely described in vitro, 
little is known about how they might benefit bacteria during the host colonization process. 
The recognition of Rho family GTPases as master regulators of cell polarity in eukaryotes [8] 
led us to hypothesize that toxin-mediated subversion of the epithelial polarity might serve as 
an important strategy for bacterial settlement in the gut. 
In the present study, we postulate that C. difficile TcdA is able to perturb epithelial 
polarity by causing redistribution of plasma membrane components between distinct surface 
domains. As a consequence, subverted cell polarity enables bacteria to gain access to the 
basolateral surface where they display a preferential association. Therefore, TcdA might play 
an important role in the colonization of colonic epithelium not only by disrupting its barrier 
function but also by perturbing epithelial polarity and promoting mucosal association. 
 
1.1. Clostridium difficile: emergence of a significant human pathogen 
1.1.1. Clinical characteristics and epidemiology of C. difficile infection 
The primary clinical manifestation of C. difficile infection (CDI) is diarrhoea, accompanied 
by fever and abdominal pain. Continuous accumulation of  C. difficile toxins in the human 
colon induce a damage of the intestinal mucosa and an acute inflammatory response. A 
sloughed-off layer of mucous, fibrin, dead epithelia and leukocytes form characteristic 
pseudomembraneous structures over the internal surface of the colon [9]. Prolonged infection 
might lead to more serious complication namely toxic megacolon, in which abnormal colon 
dilation is often accompanied by a paralysis of the peristaltic movements and the risk of 
rupture [10]. Also a kidney failure might occur in the case of severe dehydration. Any of these 
sequelae if left untreated can eventually result in patient’s death. Recent reports reveal also 
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the occurrence of  a systemic dissemination of C. difficile toxins that leads to a severe 
cardiovascular damage and consequently to death [11, 12]. 
With the widespread of overuse and/or inappropriate use of antibiotics, C. difficile 
became endemic in hospitals and chronic-care facilities worldwide. Nowadays it is recognized 
as a major cause of up to 20-25% of cases of antibiotic-associated diarrhoea and almost 100% 
of PMC [13]. Susceptibility to CDI results from the perturbations of the normal gut 
microflora induced by the exposure to almost any antibiotic and persists until the flora is fully 
restored. This might occur even a long time after the end of the therapeutic treatment.  
High risk for CDI was evidenced for ampicillin (amoxicillin) and cephalosporins that are 
widely prescribed and for which C. difficile exhibits a natural resistance [14-18]. The 
emergence of antibiotic-resistant strains of C. difficile during the last three decades resulted in 
a  series of out-breaks of CDI [19]. For instance, a common use of clindamycin for the 
treatment of colitis gave a rise to several epidemics throughout the 1980’s and 1990’s caused 
by clindamycin resistant strains [20]. These strains possessed the erm gene, which confers 
resistance to macrolides, lincosamides and streptogramins [20, 21]. Recently 
fluoroquinolones have been the major class of antimicrobials implicated in CDI, since the 
current epidemic strain exhibit high resistance to this class of broad-spectrum antibiotics [19, 
22, 23]. Fortunately, bacterial resistance to the two antibiotics primarily used for CDI 
treatment, vancomycin and metronizadole, has not emerged so far, although a significant 
increase in the amount of metronidazole required for the patient recovery has been observed 
[24]. In the search for additional treatment options, other drugs have been tested, such as 
rifaxamin, unfortunately resulting in a rapid acquisition of resistance [25]. Please refer to the 
review by Kelly and Lamont for the further details on the clinical treatment of CDI and its 
challenges [26]. 
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In the recent years, the epidemiology of CDI has changed dramatically, with increases 
noted in the morbidity and mortality of disease in North America, Canada and Europe. In 
United States, national surveillance data indicate that the number of hospital discharges with 
CDI listed as a primary diagnosis (which refers to patients for whom CDI is responsible for 
the hospitalization) or any diagnosis (which reflects discharged patients for whom CDI was 
either a primary or a secondary diagnosis, including those patients who may have contracted 
CDI during the current hospitalization, as well as those who acquired it by other means) 
increased significantly between 2000 and 2003 (Figure 1) [27]. 
 
Figure 1. Rates of discharges from U.S. short-stay hospitals of patients with C. difficile-associated disease listed 
as primary or as any diagnosis. 
Source: McDonald LC, Owings M, Jernigan DB, 2006. 
 
More recent statistics reveal even a fourfold increase in the number of hospital discharges 
with CDI between 1993 and 2009, increasing from approximately 85,700 cases in 1993 to 
336,600 cases in 2009. Patients older than 65 years of age have been most affected, 
representing over two-thirds of all patients with this disease [28]. Nevertheless, CDI is 
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increasingly recognized in patient populations previously felt to be at low risk, including 
children, healthy peripartum women, and other healthy people with no recent healthcare 
contact or antimicrobial exposure [29]. 
In parallel with the rising incidence of CDI, a significant increase in the severity of the 
disease has been observed, with greater numbers of complications and mortality related to 
CDI. Reports of CDI outbreaks in hospitals in Quebec, Canada, and subsequently in the 
United States, emerged, describing severe cases associated with higher numbers of 
colectomies, treatment failures, and deaths than were ever reported before [19, 22, 30]. For 
instance, in 2004, the mortality rate of nosocomial CDI in Quebec hospitals was 6.9%, 
compared to 1.5% among Canadian hospitals in 1997 [30, 31]. In United States, death 
certificate data showed that mortality rates from CDI increased from 5.7 per million 
population in 1999 to 23.7 per million in 2004 (Figure 2) [32]. 
 
 
Figure 2. Yearly C. difficile–related mortality rates per million population, United States, 1999–2004. Source: 
Redelings MD, Sorvillo F, Mascola L, 2007. 
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The reasons for these variations in epidemiology include changes in antimicrobial use or 
infection control practices, but also the emergence of a new hypervirulent strain of C. difficile, 
namely BI/NAP1/027. This epidemic strain was found to be associated with the outbreaks in 
Quebec and subsequently in Europe [22, 23, 30] It is known to produce 16-fold higher 
concentrations of toxin A and 23-fold higher concentrations of toxin B in vitro than 
toxinotype 0 strains [33]. Additionally it secretes another toxin called binary toxin, that may 
be associated with more severe diarrhea [34]. Therefore, the extreme virulence of the 
BI/NAP1/027 strain may result from a combination of different factors that include increased 
toxin A and B production, binary toxin, or other yet unknown determinants. 
 
1.1.2. Toxins - major virulence factors of C. difficile 
The virulence of C. difficile is conferred primarily by 2 large exotoxins, toxin A (308.0 kDa) 
and B (269.6 kDa), encoded by their genes, tcdA and tcdB, which are located on a 21-kilobase 
section of chromosomal DNA known as the pathogenicity locus (paloc). Toxin-negative C. 
difficile strains are considered nonpathogenic. In addition to toxins A and B, some strains also 
produce a binary toxin, encoded by ctdA and ctdB, located outside the paloc. The role of 
binary toxin in the pathogenesis of C. difficile remains unclear; however, its presence in 
BI/NAP1/027 epidemic strains has raised concerns about its synergism with toxins A and B in 
causing severe colitis [26].  
Belonging to the family of large clostridial toxins, C. difficile toxins A and B are 
single-chain proteins with three functional domains: (a) the C-terminally located receptor-
binding domain, (b) the middle hydrophobic domain involved in membrane translocation and 
(c) the N-terminal catalytic domain harbouring the glucosylotransferase activity (Figure 3) 
[35]. 
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Figure 3. Structure of toxin A and B from C. difficile. Toxins A and B consist of three major domains.  
Source Jank, T., T. Giesemann, and K. Aktories. 2007.  
 
Both, TcdA and TcdB, catalyse the mono-O-glucosylation of the Rho GTPases (Rho, 
Rac, Cdc42 isoforms) at a threonine residue (Thr35/37), which is essential for their switch 
from ‘inactive’, GDP-bound to ‘active’, GTP-bound state [3]. Importantly, only in the ‘on’ 
(GTP) state, GTPases are able to recognize target proteins and generate a response until GTP 
hydrolysis returns the switch to the ‘off’ state. Rho proteins are involved in numerous signal 
processes, including regulation of actin cytoskeleton, cell cycle progression, gene 
transcription, proliferation and apoptosis. They also play essential roles in host–pathogen 
interactions by participating in epithelial barrier functions, immune cell migration, 
phagocytosis and cytokine production (Figure 4) [8, 36]. Therefore the inactivation of Rho 
proteins mediated by clostridial toxins might lead to a series of sequelae, including 
disaggregation of actin cytoskeleton, increased intestinal permeability, strongly enhanced 
cytokine production, apoptosis and even cell death. 
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Figure 4. Regulation of Rho GTPases and inhibition of their function by C. difficile toxins.  
Source: Jank, T., T. Giesemann, and K. Aktories. 2007 
 
Recently Rho family GTPases have been also recognized as major evolutionarily 
conserved regulators of polarity in eukaryotic cells, from yeast to mammals. Among G-
proteins, RhoA, Cdc42, and Rac1, in particular, play essential roles in establishing polarity in 
different contexts, including asymmetric cell division, wound healing, apical–basal polarity of 
epithelial cells, and front–rear polarity of migrating cells [37-39]. Cell polarization, i.e., the 
asymmetric distribution of subcellular structures and components, is known as critical for a 
variety of biological processes in uni- and multicellular organisms [40]. 
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1.2. Polarized epithelium – a specialized barrier against pathogens 
The polarized epithelium of human mucosa serve as a barrier against endogenous microflora 
and as a first line of defence from the environment and external pathogens. This barrier is 
mainly composed by polarized epithelial cells, specialized immune cells, and secreted mucus. 
Many pathogens have evolved different strategies in order to circumvent this barrier, 
including entering and passing through the cells or crossing through intercellular junctions 
[41]. 
The mucosal barrier encountered by C. difficile during infection – colonic epithelium - 
is comprised of one layer of epithelial cells with specialized and distinct apical (AP) and 
basolateral (BL) surfaces, separated by tight junctions (TJs) [42, 43]. The apical and 
basolateral membrane domains are distinguished by unique compositions of proteins and 
lipids, creating specific membrane domains with distinct roles in formation and maintenance 
of the barrier function, as well as diverse physiological functions. The apical surface faces the 
lumen of the cavity and contains transporters and enzymes that are specialized to interact with 
the external environment. Whereas the basolateral surface faces adjoining cells and the 
underlying basement membrane. The basolateral plasma membrane contains many 
transporters and receptors that are involved in the uptake of nutrients and hormones from the 
circulation (e.g., receptors for transferrin and low-density lipoproteins) (Figure 5A). The TJs 
located at the apical-most region of the lateral surface define the boundary between the apical 
and basolateral domains [44, 45] (Figure 5B). They play pivotal roles in tissue integrity and 
maintenance of cell polarity by acting like a ‘gate’ and a ‘fence’. In particular, they aim to 
regulate the paracellular passage of molecules, including pathogens (gate function), and to 
restrict the movement of plasma membrane components between apical and basolateral 
regions (fence function) [42, 46].  
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Figure 5. Cell polarity of epithelial cells. (A) Schematic representation of the structural and functional polar 
segregation of the apical and basolateral microenvironments created by the presence of tight junction (TJ) 
membrane proteins. (B) Electron microscopic images of tight junctions (TJs), adherens junctions (AJs) and 
desmosomes. TJs are located at the most apical parts of the plasma membranes of intestinal epithelial cells, 
whereas AJs and desmosomes are localized in the more basal parts of the lateral membranes, as revealed by thin-
section electron microscopic images (a) and freeze-fracture replica images (b). Bars, 100 nm. 
Source: Tsukita, S., Y. Yamazaki, T. Katsuno, A. Tamura, and S. Tsukita. 2008 
 
1.3.  In vitro tissue culture systems to study pathogens interactions with 
polarized epithelium 
Our understanding of the interactions between pathogens and the mucosal barrier has been 
greatly aided by the use of epithelial cell lines, including dog kidney (MDCK) cells, Calu-3 
and Caco-2 cells (derived from human lung and colorectal adenocanciroma, respectively) that 
when grown in vitro on transwell inserts form a single confluent monolayer and recapitulate 
the development of polarized epithelium [47]. 
Transwell system allows cells to obtain nutrients from the basolateral medium and 
therefore to form polarized epithelium with distinct apical and basolateral surfaces and 
functional TJs within the first days of their growth. A fully polarized epithelium might be 
obtained by the continuous culture. The advantages of this in vitro system are: 
- it allows a comparison of microbe interactions between the apical and basolateral surfaces, 
- it enables studies of pathogen–epithelial interactions with distinction for the processess of 
bacterial adhesion and translocation of epithelium [41] (Figure 6A). 
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All of the epithelial cell types mentioned above can also be grown as three-
dimensional (3D) cysts when embedded in extracellular matrix [46] in order to resemble even 
more closely organs of the human body. This 3D system allows examination of pathogens 
interactions with the basolateral cell surface in the absence of the porous filter support [48, 
49]. In summary, in vitro models of polarized epithelium provide powerful platforms to 
analyze host–pathogen interactions at the mucosal cell surface, which can then be further 
validated in the animal studies. 
For the purpose of this study we have employed Caco-2 cell line, that mimic natural 
physiology and architecture of the colonic tissue in vitro. When grown in the presence of 
collagen Caco-2 cells form a polarized monolayer with dense junctional complexes in both, 
two- and three-dimensional settings, representing a very tight paracellular and trancellular 
barrier. Since C. difficile is an obligate anaerobic bacterium, our cellular model was optimized 
for the use in the anaerobic cabinet, by estimating the maximum time of incubaction (1h for 
2D and 2h for 3D cultures) using Live/Dead viability staining (Figure 6B). 
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Figure 6 In vitro Caco-2 cells model of polarized epithelium and its optimization for the use in anarobic 
conditions. (A) Schematic representation of Caco-2 monolayer grown in Transwell system and infected with 
bacteria (B) Survival of 2D Caco-2 cells system under anaerobic conditions. Cell viability was determined using 
a live/dead assay kit after 30 min, 1 h, 1.5 h and 2 h of growth under anaerobic condition. All the cells remain 
alive till 1 hour of incubation in anaerobic cabinet. Live cells (green) and dead cells (red).  
 
1.4.  Pathogens subvert host cell polarity: an emerging theme 
Recently an emerging theme in microbial pathogenesis is the recognition that several human 
mucosal pathogens, including viruses and bacteria, exploit or disrupt components of the 
mucosal barrier in order to facilitate colonization, to create a specialized niche for replication 
where they are invisbile for the host immune system, and/or to disseminate to distant tissues 
or to a new host. Host cell polarity is a logical target for pathogens, as its control requires 
constant sensing of external cues.  
Here we point out some of recently described examples of pathogenic bacteria that 
modulate epithelial cell polarity in order to successfully colonize humans and cause a disease.  
For instance, an opportunistic human pathogen Pseudomona aeruginosa is able to transform 
apical cell surface of polarized epithelium into basolateral membrane through subversion of 
the PI3K/PIP3/Akt pathway, creating a local microenvironment that facilitates its colonization 
and entry into the mucosal barrier [50]. 
Chapter 1: Introduction 
 
20 
 
Enteropathogenic Escherichia coli, a leading cause of diarrhea in children in the developing 
countries, induces relocalization of basolaterally restricted proteins, such as β1-integrin to the 
apical cell surface providing the opprotunity for their interactions with bacterial invasins, thus 
driving internalization [51].  
The disruption of epithelial barrier polarity by CagA has also been reported to create a 
nutrient-rich niche for Helicobacter pylori replication at the apical surface, allowing growth 
of microcolonies directly over the intercellular junctions [52].  
Also several viruses, including adenovirus, papillomavirus or human T-cell leukemia virus 
type 1 have been shown to target and inactivate key cell polarity proteins leading to the loss 
of polarity and disruption of cell junctions, that might have a direct function in the pathology 
of cancer [53].                                           .
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Aims of the study 
 
This study aims to a better understanding of the contribution of TcdA and TcdB in the 
pathogenesis of C. difficile infection with a specific emphasis on their role in colonization of 
polarized colonic epithelium.  
By the use of two and three-dimensional Caco-2 cell models, which resemble colonic tissue 
and mimic natural infection under anaerobic conditions, we have examined:  
   the importance of host cell polarity for their susceptibility to C. difficile infection, 
   the effects of clostridial toxins on gate and fence function of TJs and  
   the influence of toxin A-mediated subversion of cell polarity on bacterial ability to    
 colonize epithelium. 
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Chapter 2: Results 
 
2.1. Importance of the host cell polarity for their susceptibility to C. 
difficile infection 
 
2.1.1.  Cell polarity significantly affects C. difficile ability to infect Caco-2 cells 
To dissect the impact of the host cell polarity on C. difficile infection we employed a human 
colon carcinoma cell line (Caco-2) that closely resembles the natural physiology and 
architecture of human colonic tissue in vitro [54, 55]. Caco-2 cells were grown on a porous 
filter support and subsequently infected with C. difficile 630 strain either at its apical (AP) or 
basolateral (BL) side at increasing levels of cellular differentiation. The degree of epithelial 
polarity was monitored by trans-epithelial electrical resistance (TEER) and dextran flux 
measurements (Figure 7A). After one hour of incubation in anaerobic conditions the level of 
bacterial adhesion was determined by CFU counting. As shown in Fig. 1B bacteria adhere 
almost equally (p=0.4) to non-polarized Caco-2 cells (TEER 100 Ω.cm2) after infection from 
the apical or basolateral side. On the contrary, we observed a twenty times lower bacteria 
binding (p<0.0001) to the apical surface of fully polarized Caco-2 cells (TEER 600 Ω.cm2) 
compared to non-polarized cells. Overall, increasing level of polarization paralleled a rise in 
bacterial adhesion to the basolateral side of the cells and a significant drop in their ability to 
infect the apical membrane of Caco-2 cells. Moreover C. difficile displayed a preferential 
binding to the basolateral membrane, which was maximal (23-fold higher bacteria binding to 
BL cell surface compared to AP, p<0.0001) when the monolayer was infected after 21 days of 
growth (Figure 7B). Together these data suggest that the efficiency of C. difficile infection of 
epithelial cells is dependent on the state of cellular differentiation.  
 Chapter 2: Results 
 
23 
 
 
Figure 7. Cell polarization-state dependent C. difficile infection of Caco-2 cells. (A) Kinetics of TEER and 
dextran permeability during 21 days of Caco-2 monolayers growth. (B) Caco-2 cells at different stages of 
differentiation were infected either at apical (white bars) or basolateral (black bar) side with C. difficile 630 
strain. After 1 hour of incubation the number of bacteria adhering to epithelium was quantified by colony-
forming units (CFU) counting and expressed as CFU/100 cells. Nonspecific background binding of C. diffficile 
to collagen-coated empty insert was subtracted from experimental sample counts before analysis. Results are the 
mean ± SD from three independent experiments performed in triplicates. 
 
To further prove this relationship, a fully polarized Caco-2 monolayer was exposed to 
EGTA, a well-known calcium chelator able to disrupt E-cadherin mediated cell-cell contact, 
followed by C. difficile infection from the apical side. As expected, EGTA treatment caused a 
gradual and significant increase (from 2.6±0.6 to 14.8±3.7-fold increase compared to 
untreated cells) in bacterial association with Caco-2 cell surfaces (Figure 8B), which was 
consistent with the phenotype observed by confocal imaging (Figure 8C). This result further 
confirms the notion that host cell susceptibility to C. difficile infection correlates with its 
polarity status. Moreover, the EGTA-mediated alteration of epithelial barrier integrity was 
found to promote an enhanced bacterial translocation through Caco-2 monolayers, resulting in 
3 to 10 times higher number of bacteria found to penetrate epithelium compared to those that 
remained in close contact with Caco-2 cells (Figure 8B). 
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Figure 8. Increase in C. difficile capacity to colonize and penetrate epithelium induced by EGTA treatment. (A) 
Effect of EGTA on TEER and permeability to FITC-dextran (FD4) in Caco-2 monolayer. TEER is expressed as 
the percentage of the baseline value (before EGTA treatment). Each value represents the mean ± SD (n=3). (B) 
Fully polarized Caco-2 monolayers were preincubated with 4 mM EGTA for the indicated times followed by 
apical infection with C. difficile 630. After 1 hour of incubation the number of bacteria that adhered (white bar) 
or translocated across (black bar) the epithelium was quantified by CFU counting and expressed as CFU/100 
cells. Values are the mean ± SD from three independent experiments performed in triplicates. *P< 0.05; **P< 
0.01; *** P< 0.001.(C) Maximum projection (extended focus) images (MIPs) of adherent C. difficile 630 
bacteria on control and EGTA-treated Caco-2 cells. Bacteria were labeled with an anti-whole bacteria serum and 
a secondary fluorescent antibody (green), cellular actin was stained phalloidin-Alexa Fluor 568 (red). Scale bars 
10 µm. 
 
 Chapter 2: Results 
 
25 
 
2.1.2. 3D cyst model confirms the propensity of C. difficile to target basolateral 
membrane 
To further demonstrate the preferential targeting of C. difficile to the basolateral surface of the 
mucosal barrier, a 3D intestinal epithelial cell culture system was employed [56]. Caco-2 cells 
were grown in Matrigel to form hollow spheres consisting of a fully-polarized monolayer 
surrounding a central lumen, with apical side facing the lumen and basolateral side facing the 
surrounding Matrigel (BL-side-out cysts). As illustrated in Figure 9A (lower panel), proteins 
that are typically expressed at the intestinal brush border (such as atypical protein kinase C, 
aPKC) were observed to localize to the cell surface lining the lumen of the sphere. Staining of 
zonula occludens-1 (ZO-1) was observed at the level of tight junctions in the sub-apical 
region of cells. This indicates that the Caco-2 cyst model recapitulates the organization of 
human gut with structural cell polarity, as displayed by enterocytes in the intestine. 
Importantly, when an antibody against the extracellular domain of integrin β1 was added 
during the growth, cysts with opposite polarity were formed (AP-side-out cysts) (Figure 9A, 
upper panel). These spheres, while less well organized, were fully polarized as BL-side-out 
cysts. The use of Caco-2 cysts which selectively expose outward its apical or basolateral 
membrane allowed us to compare bacterial interactions with distinct cellular domains. C. 
difficile infection of AP- and BL-out-cysts was carried out for two hours under anaerobic 
conditions and was followed by qualitative and quantitative examination of bacterial binding 
to AP versus BL side (Figure 9B and C). As shown in Figure 8B, a significantly higher 
number of bacteria was found to adhere to BL-side-out compared to AP-side-out cysts 
(77.5±6 vs 11.6±1.9 bacteria/100 cells, respectively; p< 0.0001), suggesting that receptors 
localized basolaterally are a preferential target of C. difficile during colonization of the human 
gut.                                    .
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Figure 9. Adhesion of C.difficile to Caco-2 AP-side-out and BL-side-out cysts. (A) Representative single x-y confocal sections of AP-side-out or BL-side-out Caco-2 cysts 
visualized by differential interference contrast (DIC) or stained for DNA (blue), ZO-1 (red) and a marker of the apical membrane domain: aPKC (green); (B) Number of C. 
difficile 630 bacteria bound (per 100 cells) to AP-side-out versus BL-side-out Caco-2 cyst. Quantification was performed on 50 cysts for each type using Imaris software. Bars 
indicate means and each dot represents an individual Caco-2 cyst. The p-value is derived from the Mann-Whitney test; (C) Three dimensional reconstruction of one representative 
cyst for each type: AP and BL-side-out cysts were infected with C. difficile 630 for 2 hours and stained for DNA (blue), actin (red) and bacteria (green) stained. Bar, 10 µm. 
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2.2. Effects of C. difficile toxins on the host cell polarity 
 
 
2.2.1. TcdA and TcdB modulate the gate function of colonic epithelium 
Having established that host cell polarity might influence the capacity of C. difficile to 
colonize and penetrate colonic epithelium, we determined whether its toxins, known to 
disrupt epithelial barrier integrity [57-60], are also able to modulate the epithelial fence 
function. Alteration of the TJs gate function in Caco-2 monolayers pre-exposed to sub-toxic 
concentrations of TcdA and TcdB ranging between 100 to 1000 ng/ml (as determined by 
measurement of ATP in metabolically active cells) was confirmed by detecting the 
paracellular passage of fluorescently labeled 4 kDa dextran (FD4). In accordance with 
previously published observations [57-60] a dose/time-dependent increase in paracellular 
permeability for non-ionic molecules was observed in toxin-treated cells (Figure 10A and B). 
Intriguingly, the extent of this enhancement differed significantly between TcdA and TcdB, 
amounting to 8-25-fold versus and 3-12-fold, respectively, after 24 hours of exposure. 
  
 
 
Figure 10. Effect of TcdA and TcdB on gate function of tight junctions (TJs) determined by the paracellular 
passage of non-ionic tracer. Fully polarized Caco-2 cells were exposed for indicated time to different 
concentrations of TcdA (A) or TcdB (B) and paracellular flux of 4 kDa FITC-dextran was measured and 
reported as the mean Papp values of three monolayers. 
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2.2.2. TcdA, but not TcdB, is able to modify the fence function of colonic epithelium 
Then we examined whether C. difficile toxins may influence the polarity of colonic mucosa 
by perturbing the distribution of plasma membrane components between distinct surface 
domains. At first, diffusion of fluorescently labeled sphingomyelin, a lipid component of 
plasma membrane, was visualized by confocal imaging in control and toxin-treated 
monolayers. As expected, in control cells the fluorescent lipid complex added apically was 
found to easily intercalate and diffuse within outer leaflet of the bilayer giving an evident 
staining of the apical membrane. On the contrary, upon EGTA (positive control) or TcdA 
treatment, diffusion of the lipid was no longer limited, leading to lateral and basolateral 
membrane labeling, as shown in confocal z-sections (Figure 11A). Slight staining of lateral 
membranes was also detected in cells treated with TcdB (500 and 1000 ng/ml), presumably as 
a result of lipid diffusion in solution across disrupted TJs. These data suggest that, beside the 
mutual effect of toxins on cellular permeability, alteration in TJs fence function is 
predominantly induced by TcdA. To further examine this specific modulation of cellular 
organization, changes in the polarized distribution of plasma membrane proteins in 
monolayers exposed to C.difficile toxins were assessed by immunofluorescence staining of 
apical (atypical protein kinase C, aPKC) and basolateral proteins (E-cadherin). Additionally 
ZO-1 labeling was simultaneously performed to reveal the precise localization of TJs. As 
shown in Figure 11B, Caco-2 monolayers exposed to EGTA or TcdA displayed a significant 
displacement of cell membrane constituents, including expansion of aPKC to lateral cell 
membranes and E-cadherin staining localized all around the cells. Also the distribution of ZO-
1 was evidently altered. No changes in the distinct composition of plasma membrane proteins 
were observed in response to TcdB. Together these observations demonstrate that sub-toxic 
concentrations of TcdA, but not TcdB, are able to affect both barrier function (gate function) 
of the epithelium, as well as to subvert cell polarity (fence function).                                  .
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Figure 11. Effect of TcdA and TcdB on the fence function of tight junctions (TJs). Fully polarized Caco-2 monolayers were treated with indicated concentrations of toxins or 
with 4mM EGTA for 30 minutes or incubated in control medium. The membrane distribution of the fluorescent markers was determined by z sectioning by confocal microscopy. 
(A) Bodipy FL-C5-sphingomyelin/BSA complex diffusion assay. Fluorescent lipid/BSA was loaded to the apical surface. Arrows indicate lateral membrane staining. (B) 
Distribution of plasma membrane proteins specific for apical (aPKC, white) or basolateral (E-cadherin, green) membrane. TcdA and EGTA treated monolayers show 
compromised apicobasal polarity. The arrowheads denote the mislocalized membrane proteins whereas red staining indicates localization of ZO-1 in TJ region. Nuclei are stained 
with DAPI (blue). Bar, 10 µm.                                                                        .
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2.2.3. TcdA subversion of host cell polarity is not due to apoptosis 
Since C. difficile toxins are known to induce apoptosis in many cells types, we wanted 
exclude the possibility that TcdA effect on epithelial polarity may be triggered by apoptosis. 
Thus in order to evaluate the presence of apoptotic cells in ours assays a double staining of 
activated caspase-3 and TUNEL was performed (Figure 12A). Caspase-3 cleavage is an early 
event that initiates apoptosis whereas nuclear DNA fragmentation detected by TUNEL assay 
is observed at the very late states of cellular death. The percentage of active caspase-3 and 
TUNEL-positive cells in monolayers treated with different concentrations of TcdA or TcdB 
for 16 hours (the maximum incubation time used in this study) was determined and compared 
with the positive and negative controls (Figure 12B). Cells incubated with 2 µm staurosporine 
for 8 hours were used as a positive control showing high rates of apoptosis (23±0.5% of 
TUNEL-positive cells, 21±6% of active caspase-3-positive cells). In contrast in untreated 
cultures less than 1% of cells were TUNEL or active caspase-3-positive (0.5±0.3% of 
TUNEL- and 0.2±0.1% of active caspase-3-positive cells). Treatment with C. difficile toxins 
in concentrations between 100 and 1000 ng/ml did not induce a significant increase in Caco-2 
apoptosis rates, even after prolonged incubation period of 16 hours. Therefore we can 
conclude that TcdA-induced depolarization of Caco-2 cells is not a secondary effect of 
apoptosis.  
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Figure 12. Effect of sub-lethal concentrations of C. difficile toxins on Caco-2 apoptosis. (A) Assessment of 
Caco-2 cells apoptosis by TUNEL assay (green) and immunostaining for cleaved caspase-3 (red) after treatment 
with 1000 ng/ml of TcdA or TcdB for 16 hours or 2µM staurosporine (STS) for 8 hours (as a positive control). 
Merged microphotographs demonstrate the simultaneous presence of active caspase-3 and fragmented DNA in 
apoptotic cells. Nuclei were stained with Hoechst (blue). Bar, 10 µm. (B) Quantification of TUNEL and active 
caspase-3 positive cells using ImageJ software. Values are the mean from three independent experiments 
performed in triplicate.**P <0.01;  ***P < 0.001. 
 
 
Chapter 2: Results 
32 
 
2.3. Influence of TcdA-mediated subversion of cell polarity on C. difficile 
ability to colonize epithelium 
 
2.3.1. TcdA-mediated subversion of cell polarity facilitates C. difficile adhesion and 
translocation of Caco-2 monolayer 
Since our results suggested that cell polarity was a deterrent to C. difficile colonization of the 
host cell surface, and that TcdA was able to alter this epithelial function, we asked whether 
this activity could play a beneficial role in establishment of C. difficile infection. Being 
unable to compare C. difficile wild-type and toxin mutant strains in our infection assay 
because of drastically limited time of Caco-2 survival in anaerobic condition (less than 2 
hours), we tested the effect of purified toxins on C. difficile capacity to infect human cells. 
Briefly, fully polarized Caco-2 monolayers were pre-exposed to different concentrations of 
TcdA or TcdB for 16 hours followed by incubation with C. difficile 630 at the apical side. In 
order to monitor toxin action in our in vitro assay, FITC-dextran was added simultaneously to 
the inner chamber of the Transwell system (Figure 13A). As a result striking differences were 
observed in the ability of C. difficile 630 strain to colonize cells in vitro in the presence or 
absence of TcdA (Figure 13B and C). Statistically significant increase in bacterial adhesion 
rates were noticed in Caco-2 monolayers pre-exposed to 500 ng/ml and 1000 ng/ml of TcdA 
(2.6±0.2 and 5.3±0.2-fold, respectively). The influence of the highest concentration tested on 
the number of adherent bacteria was comparable to the effect promoted by 30 minutes of 
EGTA treatment (44.4±5 bacteria/100 cells in toxin-treated monolayers versus 40.7±7 
bacteria/100 cells in EGTA-exposed monolayers). However, as shown in Figure 13B, 
bacterial translocation is only slightly enhanced by sub-toxic doses of TcdA without reaching 
the levels observed upon EGTA treatment (Figure 11B).  
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Figure 13. Effect of TcdA on 630 C. difficile colonization of colonic mucosa (A) Effect of TcdA on epithelial 
polarity determined by TEER and dextran flux measurements. TEER is expressed as the percentage of the 
baseline value (before TcdA treatment). Each value represents the mean ± SD (n=3). (B) Fully polarized Caco-2 
monolayers were preincubated with indicated concentrations of TcdA for 16 hours followed by apical infection 
with C. difficile 630 strain. After 1 hour of incubation the number of bacteria that adhered (white bar) or 
translocated across (black bar) the epithelium was quantified by CFU counting and expressed as CFU/100 cells. 
Values are the mean ± SD from three independent experiments performed in triplicates. **P<0.01; ***P<0.001. 
(C) MIPs of adherent C. difficile bacteria on control and TcdA-treated Caco-2 cells. Bacteria were labeled with 
an anti-whole bacteria serum and a secondary fluorescent antibody (green) and cellular actin was stained 
phalloidin-Alexa Fluor 568 (red). Scale bars 10 µm. 
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Similar results were obtained by incubating cells with C. difficile R20291 (Stoke Mandeville), 
characterized as an epidemic and hypervirulent strain (Figure 14), indicating that this 
phenotype is not strain specific.  
 
Figure 14. Effect of TcdA on R20291 C. difficile colonization of colonic mucosa. Fully polarized Caco-2 
monolayers were preincubated with indicated concentrations of TcdA for 16 hours followed by apical infection 
with C. difficile R20291 (Stoke Mandeville). After 1 hour of incubation the number of bacteria that adhered 
(white bar) or translocated across (black bar) the epithelium was quantified by CFU counting and expressed as 
CFU/100 cells ± SD. Values are the mean ± SD from three independent experiments performed in triplicates. 
*P<0.05; **P<0.001. 
 
 
 
Strikingly, no differences in bacterial adhesion between control and TcdA-treated cells were 
observed when only partially polarized (4-days-old) monolayers were infected confirming 
again that epithelial polarity is an important target of C. difficile pathogenesis (Figure 15).  
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Figure 15. Effect of TcdA on C. difficile colonization of partially polarized Caco-2 cells. (A) Effect of TcdA on 
epithelial polarity determined by TEER and dextran flux measurements. TEER is expressed as the percentage of 
the baseline value (before TcdA treatment). Each value represents the mean ± SD (n=3). (B) Four days-old 
Caco-2 monolayers were preincubated with indicated concentrations of TcdA for 16 hours followed by apical 
infection with C. difficile 630 strain. After 1 hour of incubation the number of bacteria that adhered (white bar) 
or translocated across (black bar) the epithelium was quantified by CFU counting and expressed as CFU/100 
cells ± SD. Values are the mean ± SD from three independent experiments performed in triplicates. **P<0.01; 
***P<0.001. 
 
Moreover, polarized monolayer exposure to TcdB was not able to facilitate colonization of 
Caco-2 cells (Figure 16), in line with the evidence that this toxin is not able to interfere with 
polarization status. 
 
 
 
Figure 16. Effect of TcdB on 630 C. difficile. colonization of colonic mucosa (A) Effect of TcdB on epithelial 
polarity determined by TEER and dextran flux measurements. TEER is expressed as the percentage of the 
baseline value (before TcdB treatment). Each value represents the mean ± SD (n=3). (B) Fully polarized Caco-2 
monolayers were preincubated with indicated concentrations of TcdB for 16 hours followed by apical infection 
with C. difficile 630 strain. After 1 hour of incubation the number of bacteria that adhered (white bar) or 
translocated across (black bar) the epithelium was quantified by CFU counting and expressed as CFU/100 cells ± 
SD. Values are the mean ± SD from three independent experiments performed in triplicates.**P<0.1
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An important aspect in the understanding of microbial pathogenesis is the recognition of the 
different strategies evolved by bacteria and viruses to circumvent or disrupt the mucosal 
barrier in order to facilitate colonization and/or dissemination to distal tissues. These can be 
achieved by a specific pathogen-mediated subversion of the host cell organization and 
functions [61]. In particular, a number of mucosal pathogens, including Pseudomonas 
aeruginosa, Helicobacter pylori and enteropathogenic Escherichia coli, have been shown to 
directly target various components of the polarity regulation network [51, 52, 62]. The data 
reported in this study postulate that this scenario may also apply to C. difficile infection with 
TcdA playing a major role in the alteration of epithelial cell polarity, leading to increased 
adhesion to the host cell surface.  
By the use of epithelial Caco-2 cells grown on Transwell inserts to mimic natural 
architecture and tissue polarity in vitro, we found that the establishment of C. difficile 
infection strongly depends on the state of cellular differentiation, further reinforcing studies 
previously undertaken by Cerquetti and colleagues [63]. The use of the Transwell system 
allowed us to precisely distinguish between bacterial adhesion and translocation rates and to 
demonstrate that both processes are significantly enhanced in monolayers whose fence and 
gate function are not fully established or have been altered by calcium chelation. This is 
consistent with the preferential tropism of C. difficile to the basal cell surface observed in 2 
and 3D Caco-2 cell models. Taken together our findings suggest that C. difficile might exploit 
a nutrient-rich niche located directly beneath the epithelium to persist in the human colon.  
Chapter 3: Discussion 
 
37 
 
Although the effect of TcdA and TcdB, recognized as main virulence factors of C. 
difficile, on the structure of cytoskeleton and the function of TJs has been a topic of an intense 
study, the fundamental question of how they might benefit bacteria during host colonization 
remains unanswered [64, 65]. Moreover our current understanding of the molecular 
mechanism of C. difficile toxins action is mainly based on the in vitro studies using highly 
toxic concentrations that lead to increased paracellular permeability and apoptotic or necrotic 
cell death [58-60, 66-68]. Since toxin production in vitro usually ranges from 50 to 2000 
ng/ml in 24 hours of C. difficile growth [69], it is likely that the local concentration of TcdA 
and TcdB in the colon of C. difficile-infected patients may reach similar levels. Based on the 
evidence reported in this study, we hypothesize that C. difficile may initiate its association 
with the colonic mucosa by producing low amounts of toxin A that could facilitate the first 
steps of colonization. Indeed, the alteration of plasma membrane components distribution 
between distinct surface domains of TcdA-treated Caco-2 cells together with the previously 
mentioned C. difficile preference for the basolateral membrane suggests that subversion of 
host cell polarity might act as a key mechanism leading to the increased bacterial binding. 
This notion might also explain why in vivo adhesion of an avirulent non-toxinogenic strain is 
facilitated by co-administration of C. difficile toxins in hamster model [70]. In this context, 
also the elevated rate of intestinal colonization in healthy adults infected by toxigenic C. 
difficile suggest that minimal level of toxin production could facilitate the colonization state 
without the occurrence of clinical symptoms [71, 72]. On the contrary, toxin B beside its 
expected influence on bacterial translocation rates does not play role in the establishment of 
the apical surface association consistent with its inability to modulate epithelial fence 
function.  
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Segregation of apical and basolateral receptors at the epithelial cell surface, and the 
compartmentalization of different cytoplasmic and membrane-associated signaling molecules, 
is crucial for the regulation of an innate immune response to pathogens in polarized 
epithelium and for prevention of unrestrained or prolonged inflammation. Under normal 
healthy circumstances several toll-like receptors (TLRs), such as TLR5, that recognize 
pathogen-associated molecular patterns (PAMPs) and activate innate immune pathways are 
physically separated from the luminal content. This allows epithelial cells to mount a rapid 
pro-inflammatory response only if surface or secreted components from commensal or 
pathogenic bacteria have breached the epithelial barrier [73]. Therefore, alterations in cell 
polarity induced by C. difficile toxins may allow PAMPs to access the BL surface and trigger 
the production of inflammatory cytokines and chemokines. Activation of different TLRs, 
including TLR4 and TLR5, by several C. difficile components (ie, surface layer proteins and 
flagellin) is known to play a pivotal role in determining the final outcome of infection [74, 
75]. Notably, Yoshino and colleagues [75]recently demonstrated the contribution of 
clostridial toxins in this process, showing that breaching of epithelial barrier function by C. 
difficile toxin might lead to more severe inflammation present at the site of infection. 
Therefore, as postulated in this study, modulation of cell polarity by TcdA may not only 
facilitate colonization of the gut mucosa, but may also play a role in landscaping the immune 
response. 
Taken together, our concept on C. difficile pathogenesis that combines the current 
knowledge with the results obtained in this study and depicted in the diagram (Figure 16) 
propose that different local levels of C. difficile toxins as well as the time of exposure might 
serve as a fine tuning of cell epithelial barrier ranging from mild alterations of its polarity, to 
induction of acute inflammation, apoptotic signaling and cell death. This specific modulation 
of mucosal organization and functions might facilitate C. difficile settlement in the human gut 
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and development of the chronic and persistent infection. In conclusion, we suggest TcdA-
mediated subversion of the epithelial polarity as a novel strategy used by C. difficile to 
enhance its ability to reside in a very competitive environment of the human gut. 
 
Figure 17. Schematic diagram illustrating the proposed model of the pathogenesis of C. difficile infection, that 
have partly emerged from the experiments reported in this study. Low levels of TcdA present locally in the gut 
of C. difficile-infected individuals perturb epithelial polarity leading to exposure of toll-like (TLR) and other 
basolaterally localized receptors to luminal bacteria and their products (pathogen-associated molecular patterns, 
PAMPs). This promotes an increased colonization of colonic mucosa and stimulates production of inflammatory 
cytokines at the sites of infection. Subsequent increase in mucosal permeability, damage to the intestinal 
epithelial tissue and bacterial dissemination lead to development of acute and chronic inflammation, fluid 
secretion and diarrhea. 
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Chapter 4: Experimental Procedures 
 
4.1. C. difficile strains and culture conditions 
C. difficile strains 630 and B1/NAP1/027 R20291 were kindly provided by Nigel Minton 
(University of Nottingham, Nottingham, UK). Strains were grown on BHI-agar or in BHI-
broth (Bacto, USA) at 37°C in anaerobic conditions. For infection studies, C. difficile strains 
were grown in BHI-broth until an OD600 of 0.5 (early exponential phase). 
 
4.2. 2D and 3D cell cultures 
The colon adenocarcinoma cell line Caco-2 (obtained from the American Type Culture 
Collection) was cultured in DMEM/F12 (Invitrogen) supplemented with 10% heat-inactivated 
FBS (Invitrogen), 20 mmol/L HEPES, 100 nmol/L nonessential amino acids and 100 μg/ml of 
penicillin/streptomycin and used between passage numbers 20–25. Cells were grown as 2D 
monolayers on collagen-coated Transwell inserts (3-μm-pore size, BD Biosciences) at a 
seeding density of 105 cells/insert and supplemented with fresh media every day. Unless 
stated otherwise, cells were allowed to differentiate for 21 days. To disrupt calcium-
dependent intercellular junctions, monolayers were transiently exposed to 4mM EGTA [76]. 
Cell polarity and tight junction barrier function were verified by TEER and dextran flux 
measurements as described previously [77]. For 3D cell culture, Caco-2 cells were grown as 
cysts in Matrigel as described previously [56].  
Briefly, a cell:matrigel mix containing 5.8 x 104 cells/ml, 0.02 M HEPES, pH 7.4, 1 mg/ml 
Collagen I (Sigma-Aldrich) and 40% Growth Factor Reduced BD Matrigel™ Matrix was 
plated on 8-well chamber slide (BD Biosciences) incubated at 37°C, 5% CO2 for 1 hour to 
solidify and overlaid with complete growth media. Cysts were allowed to develop for 14-16 
days at 37°C, 5% CO2, changing media every day, to form BL-side-out cysts with AP 
membrane facing the lumen and BL membrane facing surrounding collagen. In order to 
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produce the spheres with opposite polarity the anti-integrin beta-1 antibody AIIB2 (1:100 
dilution, Developmental Studies Hybridoma Bank, University of Iowa) was added for entire 
culture period. Under these conditions, polarized AP-side-out cysts were formed.  
 
4.3. Dextran permeability and membrane diffusion assays 
These assays were performed as described elsewhere [78]. Briefly, 2D Caco-2 cell cultures 
were washed with ice-cold HBSS/HEPES buffer and labeled on the apical side with 5 μM 
solution of BODIPY-FL-C5-sphingomyelin/BSA complex (Molecular Probes) for 10 minutes 
on ice. Inserts were rinsed with ice-cold HBSS/HEPES buffer, incubated for 1 hour on ice and 
immediately observed by confocal microscopy. Paracellular permeability was quantified 
measuring the transepithelial flux of a 4 kDa fluorescein isothiocyanate (FITC)-labeled 
dextran (Sigma-Aldrich) [77] and expressed as apparent permeability coefficient (Papp): Papp 
(cm/s) = dQ / dt (1 / AC0), where dQ / dt is the permeability rate (μg/s), C0 is the initial 
concentration in the upper chamber (μg/ml), and A is the surface area of the membrane (cm2) 
[79]. 
 
4.4. Immunofluorescence microscopy 
2D Caco-2 cultures pretreated with TcdA, TcdB, EGTA or medium alone were rinsed with 
Dulbecco’s phosphate-buffered saline (DPBS), fixed with 4% paraformaldehyde, 
permeabilized and blocked with 3% [wt/vol] bovine serum albumin (blocking buffer) in 
DPBS. Incubation with primary antibodies, including rabbit anti-ZO-1 antibody (61-7300, 
Invitrogen), mouse anti E-cadherin (33-4000, Invitrogen), and goat anti-PKCç antibody (sc-
216-G, Santa Cruz Biotechnology), was performed either overnight at 4°C or for 2 hour at 
room temperature and followed by the treatment with the appropriate Alexa fluor-conjugated 
secondary antibody. Samples were mounted using ProLong Gold Antifade Reagent with 
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DAPI (Invitrogen) and analyzed by confocal microscopy using Zeiss LSM 710. Z-stacks 3D 
reconstructions were performed by Imaris software (BitPlane Inc.). 
 
4.5. Assessment of apoptosis by TUNEL assay and active caspase-3 staining 
The effect of TcdA and TcdB on Caco-2 apoptosis was assessed by immunostaining of active 
caspase-3 and by the recombinant terminal deoxynucleotidyl transferase (rTdT) mediated 
dUTP Nick End Labelling (TUNEL). Caco-2 cells grown on transwell inserts were exposed 
to different concentrations of TcdA or TcdB (100, 500, and 1000 ng/ml) for 16 hours. 
Subsequently cells were stained by TUNEL assay kit according to manufacturer’s instructions 
(Invitrogen). For caspase-3 activation cells were counterstained with anti-active caspase-3 
rabbit polyclonal antibody (9661, Cell Signalling Technologies), followed by the appropriate 
Alexa fluor-conjugated secondary antibody. As a positive control Caco-2 cells were treated 
with 2 μM staurosporine (Sigma-Aldrich) for 8 hours. Cells were examined with a Zeiss LSM 
710 confocal laser scanning microscope. Apoptosis was quantified as the percentage of cells 
showing TUNEL-positive nuclei and active-caspase-3. 
 
4.6. C. difficile adhesion and translocation assay on 2D Caco-2 monolayers 
2D Caco-2 cultures were transferred into anaerobic cabinet and washed once with pre-reduced 
HBSS. Bacteria from exponential phase cultures were pelleted, resuspended in cell culture 
medium and apically added to the monolayers for 1 hour. Dextran solution was applied 
simultaneously to monitor monolayer integrity during infection. Bacterial translocation was 
determined by colony-forming unit (CFU) counting of bacteria recovered from the outer 
chamber of the Transwell system. After extensive washings and cells lysis with 1% saponin; 
adherent bacteria were counted by plating appropriate dilutions on BHI-agar. Optimal 
multiplicity of infection (MOI of 1:20) and maximum incubation time of Caco-2 monolayers 
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in anaerobic conditions were determined in the initial experiments (data not shown). To test 
the effect of toxins on the capacity of C. difficile to infect epithelial cells, Caco-2 monolayers 
were preincubated with TcdA or TcdB (100, 500, 1000 ng/ml) for 16 hours. 
 
4.7. C. difficile infection of 3D Caco-2 cysts 
After treatment with 100 U/ml Collagenase VII (Sigma) for 15 minutes at 37°C to allow 
bacterial access to the cells surface, cysts were infected with 107 bacteria from exponential 
phase cultures and incubated for 2 hours under anaerobic conditions. Cultures were then 
washed three times to remove unbound bacteria, fixed with 4% paraformaldehyde for 30 
minutes at room temperature and blocked with blocking buffer for 1 hour at room 
temperature. Incubation with primary rabbit anti-ZO-1 antibody (Invitrogen) and goat anti-
PKCç antibody (Santa Cruz) or an anti-whole bacteria serum was performed overnight at 4°C, 
and was followed by the incubation with fluorophore-conjugated secondary antibodies for 1 
hour at room temperature. Finally, cysts were washed, mounted and analyzed by confocal 
microscopy. Bacterial binding to 3D cysts was quantified using Imaris, as further described in 
Supplementary data, on 3D reconstruction of images acquired with Zen2009 software.  
 
4.8. Quantification of C. difficile binding to 3D Caco-2 cysts 
Imaris 3D analysis software was used to quantify bacterial adhesion to 3D cysts. Briefly, 
image stacks obtained by confocal microscopy were reconstructed with Imaris into 3D 
‘‘surface objects’’ for two microscopy channels, one for fluorescently stained bacteria, the 
other for DAPI-stained nuclei of Caco-2 cells. The number of  ‘‘surface objects’’ for each 
channel was determined using a “splitting touching objects” option and size threshold criteria. 
Any object above the minimal (for bacterial aggregates) or below the maximal (for the nuclei 
of Caco-2 cells) size threshold was counted as one. 50 cysts were quantified for each type: 
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AP- and BL-side-out. Results are expressed as the number of C. difficile bound to 100 Caco-2 
cells, where one sphere consists of 25-40 cells. 
 
4.9. Statistical analyses 
All experiments were performed at least three times in triplicates. Statistical analyses were 
performed using the non-parametric Mann-Whitney U test. 
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